Login
$ITP
$0.12 -$0.00 (0.41%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Q4 FY2020
As of Dec 31, 2020
Current Assets
Cash and bank balances
Accounts receivable (net of allowance for doubtful accounts of $48,646 and $881,878 as of June 30, 2023 and December 31, 2022, respectively)
Restricted cash
Accounts receivable (net of allowance for doubtful accounts of $90,225 and $53,111 as of September 30, 2025 and December 31, 2024, respectively)
Inventories
Prepayments and other current assets
Due from related parties
Related Party
Total due from related parties
Total current assets
Prepayment on property, plant and equipment
Operating lease right-of-use assets, net
Property, plant, and equipment, net
Value-added tax recoverable
Total Assets
Current Liabilities
Short-term bank loans
Current portion of long-term loans
Lease liability
Accounts payable
Notes payable
Advance from customers
Due to related parties
Related Party
Total due to related parties
Accrued payroll and employee benefits
Other payables and accrued liabilities
Income taxes payable
Total current liabilities
Long-term loans
Deferred gain on sale-leaseback
Lease liability - non-current
Derivative liability
Total liabilities (including amounts of the consolidated VIE without recourse to the Company of $18,629,300 and $16,976,765 as of September 30, 2025 and December 31, 2024, respectively)
Stockholders’ Equity
Common stock $0.001 par value per share; Authorized: 50,000,000 shares; Issued and outstanding: 16,965,420 shares as of September 30, 2025 and 10,065,920 shares as of December 31, 2024, respectively.
Additional paid-in capital
Statutory earnings reserve
Accumulated other comprehensive loss
Retained earnings
Total stockholders’ equity
Total Liabilities and Stockholders’ Equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support